• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.胰岛素样生长因子(IGF)结合蛋白-5与平滑肌细胞细胞外基质的结合是细胞对IGF-I反应的主要决定因素。
Mol Biol Cell. 1998 Sep;9(9):2383-92. doi: 10.1091/mbc.9.9.2383.
2
Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
J Biol Chem. 1996 Mar 15;271(11):6099-106. doi: 10.1074/jbc.271.11.6099.
3
Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.血小板反应蛋白和骨桥蛋白与胰岛素样生长因子(IGF)结合蛋白-5结合,导致IGF-I刺激的细胞生长发生改变。
Endocrinology. 2000 Mar;141(3):1100-6. doi: 10.1210/endo.141.3.7386.
4
Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5.胰岛素样生长因子结合蛋白-5(IGFBP-5)的一个肽片段对IGFBP-5与细胞外基质结合及IGF-I刺激的DNA合成的抑制作用
J Cell Biochem. 1998 Dec 1;71(3):375-81.
5
Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.胰岛素样生长因子结合蛋白-5(IGFBP-5)与血小板反应蛋白-1相互作用,对IGF-I的作用产生负调节效应。
J Cell Physiol. 2005 May;203(2):328-34. doi: 10.1002/jcp.20343.
6
Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.胰岛素样生长因子结合蛋白5的蛋白酶抗性形式是胰岛素样生长因子-I对培养的猪平滑肌细胞作用的抑制剂。
J Clin Invest. 1997 Nov 15;100(10):2596-605. doi: 10.1172/JCI119803.
7
Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5.
J Biol Chem. 1996 Jun 7;271(23):13523-9. doi: 10.1074/jbc.271.23.13523.
8
Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.人成纤维细胞和猪主动脉平滑肌细胞对胰岛素样生长因子结合蛋白-5蛋白酶合成与分泌的调控
Endocrinology. 2003 Jun;144(6):2489-95. doi: 10.1210/en.2002-220896.
9
The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I.细胞外基质蛋白对猪平滑肌细胞胰岛素样生长因子(IGF)结合蛋白-5合成及对IGF-I反应性的影响。
J Biol Chem. 1998 Apr 10;273(15):8994-9000. doi: 10.1074/jbc.273.15.8994.
10
Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I.大鼠胰岛素样生长因子结合蛋白(IGFBP)-5细胞外基质(ECM)结合区域(201-218)内的氨基酸是结合IGF-I的重要决定因素。
J Mol Endocrinol. 1999 Aug;23(1):117-23. doi: 10.1677/jme.0.0230117.

引用本文的文献

1
Implications of the PAPP-A-IGFBP-IGF-1 pathway in the pathogenesis and treatment of polycystic kidney disease.PAPP-A-IGFBP-IGF-1 通路在多囊肾病发病机制和治疗中的意义。
Cell Signal. 2020 Sep;73:109698. doi: 10.1016/j.cellsig.2020.109698. Epub 2020 Jun 20.
2
Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease.胰岛素样生长因子结合蛋白-5在生理与疾病中的作用
Front Endocrinol (Lausanne). 2020 Mar 3;11:100. doi: 10.3389/fendo.2020.00100. eCollection 2020.
3
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.综合数据分析揭示了具有不同驱动途径和生物标志物的子宫平滑肌瘤亚型。
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1315-20. doi: 10.1073/pnas.1518752113. Epub 2016 Jan 19.
4
IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF.胰岛素样生长因子结合蛋白5(IGFBP-5)独立于其向细胞核的转位及其与核仁素和胰岛素样生长因子(IGF)的相互作用促进纤维化。
PLoS One. 2015 Jun 23;10(6):e0130546. doi: 10.1371/journal.pone.0130546. eCollection 2015.
5
Differences in gene expression between strabismic and normal human extraocular muscles.斜视与正常人类眼外肌之间的基因表达差异。
Invest Ophthalmol Vis Sci. 2012 Aug 3;53(9):5168-77. doi: 10.1167/iovs.12-9785.
6
IGF-I/IGFBP system: metabolism outline and physical exercise.IGF-I/IGFBP 系统:代谢概述与身体运动。
J Endocrinol Invest. 2012 Jul;35(7):699-707. doi: 10.3275/8456. Epub 2012 Jun 18.
7
Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers.胰岛素样生长因子结合蛋白5在不同类型癌症中的功能作用及临床价值
Chin J Cancer. 2012 Jun;31(6):266-80. doi: 10.5732/cjc.011.10405. Epub 2012 Feb 7.
8
Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.胰岛素样生长因子结合蛋白-2 对于破骨细胞分化是必需的。
J Bone Miner Res. 2012 Feb;27(2):390-400. doi: 10.1002/jbmr.545.
9
Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?胰岛素样生长因子-I 对免疫功能的调节:自身免疫性疾病的潜在治疗靶点?
Pharmacol Rev. 2010 Jun;62(2):199-236. doi: 10.1124/pr.109.002469. Epub 2010 Apr 14.
10
Duplicated zebrafish insulin-like growth factor binding protein-5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity.具有分裂功能域的重复斑马鱼胰岛素样生长因子结合蛋白-5 基因:进化上保守的 IGF 结合、核定位和反式激活活性的证据。
FASEB J. 2010 Jun;24(6):2020-9. doi: 10.1096/fj.09-149435. Epub 2010 Jan 15.

本文引用的文献

1
Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.胰岛素样生长因子结合蛋白5的蛋白酶抗性形式是胰岛素样生长因子-I对培养的猪平滑肌细胞作用的抑制剂。
J Clin Invest. 1997 Nov 15;100(10):2596-605. doi: 10.1172/JCI119803.
2
Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I.
Endocrinology. 1997 Jul;138(7):2972-8. doi: 10.1210/endo.138.7.5230.
3
Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.胰岛素样生长因子(IGF)I 或 II 与 IGF 结合蛋白 -2 的结合使其能够与肝素和细胞外基质结合。
Endocrinology. 1996 Nov;137(11):4571-5. doi: 10.1210/endo.137.11.8895319.
4
Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5.
J Biol Chem. 1996 Jun 7;271(23):13523-9. doi: 10.1074/jbc.271.23.13523.
5
Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells.
J Biol Chem. 1996 Feb 23;271(8):4280-8. doi: 10.1074/jbc.271.8.4280.
6
Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
J Biol Chem. 1996 Mar 15;271(11):6099-106. doi: 10.1074/jbc.271.11.6099.
7
Efficient DNA transfection of quiescent mammalian cells using poly-L-ornithine.使用聚-L-鸟氨酸对静止哺乳动物细胞进行高效DNA转染
Nucleic Acids Res. 1993 Feb 11;21(3):771-2. doi: 10.1093/nar/21.3.771.
8
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.骨桥蛋白在大鼠动脉新生内膜形成过程中升高,是人类动脉粥样硬化斑块的一种新成分。
J Clin Invest. 1993 Oct;92(4):1686-96. doi: 10.1172/JCI116755.
9
Betaglycan presents ligand to the TGF beta signaling receptor.β聚糖将配体呈递给转化生长因子β信号受体。
Cell. 1993 Jul 2;73(7):1435-44. doi: 10.1016/0092-8674(93)90368-z.
10
Insulin-like growth factors and their binding proteins: biological actions.胰岛素样生长因子及其结合蛋白:生物学作用
Endocr Rev. 1995 Feb;16(1):3-34. doi: 10.1210/edrv-16-1-3.

胰岛素样生长因子(IGF)结合蛋白-5与平滑肌细胞细胞外基质的结合是细胞对IGF-I反应的主要决定因素。

Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.

作者信息

Parker A, Rees C, Clarke J, Busby W H, Clemmons D R

机构信息

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

出版信息

Mol Biol Cell. 1998 Sep;9(9):2383-92. doi: 10.1091/mbc.9.9.2383.

DOI:10.1091/mbc.9.9.2383
PMID:9725901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC25505/
Abstract

Insulin-like growth factor-binding protein-5 (IGFBP-5) has been shown to bind to fibroblast extracellular matrix (ECM). Extracellular matrix binding of IGFBP-5 leads to a decrease in its affinity for insulin-like growth factor-I (IGF-I), which allows IGF-I to better equilibrate with IGF receptors. When the amount of IGFBP-5 that is bound to ECM is increased by exogenous addition, IGF-I's effect on fibroblast growth is enhanced. In this study we identified the specific basic residues in IGFBP-5 that mediate its binding to porcine smooth-muscle cell (pSMC) ECM. An IGFBP-5 mutant containing alterations of basic residues at positions 211, 214, 217, and 218 had the greatest reduction in ECM binding, although three other mutants, R214A, R207A/K211N, and K202A/R206N/R207A, also had major decreases. In contrast, three other mutants, R201A/K202N/R206N/R208A, and K217N/R218A and K211N, had only minimal reductions in ECM binding. This suggested that residues R207 and R214 were the most important for binding, whereas alterations in K211 and R218, which align near them, had minimal effects. To determine the effect of a reduction in ECM binding on the cellular replication response to IGF-I, pSMCs were transfected with the mutant cDNAs that encoded the forms of IGFBPs with the greatest changes in ECM binding. The ECM content of IGFBP-5 from cultures expressing the K211N, R214A, R217A/R218A, and K202A/R206N/R207A mutants was reduced by 79.6 and 71.7%, respectively, compared with cells expressing the wild-type protein. In contrast, abundance of the R201A/K202N/R206N/R208A mutant was reduced by only 14%. Cells expressing the two mutants with reduced ECM binding had decreased DNA synthesis responses to IGF-I, but the cells expressing the R201A/K202N/R206N/R208A mutant responded well to IGF-I. The findings suggest that specific basic amino acids at positions 207 and 214 mediate the binding of IGFBP-5 to pSMC/ECM. Smooth-muscle cells that constitutively express the mutants that bind weakly to ECM are less responsive to IGF-I, suggesting that ECM binding of IGFBP-5 is an important variable that determines cellular responsiveness.

摘要

胰岛素样生长因子结合蛋白5(IGFBP - 5)已被证明能与成纤维细胞外基质(ECM)结合。IGFBP - 5与细胞外基质的结合导致其对胰岛素样生长因子 - I(IGF - I)的亲和力降低,这使得IGF - I能更好地与IGF受体达到平衡。当通过外源添加增加与ECM结合的IGFBP - 5的量时,IGF - I对成纤维细胞生长的作用增强。在本研究中,我们确定了IGFBP - 5中介导其与猪平滑肌细胞(pSMC)ECM结合的特定碱性残基。一个在第211、214、217和218位碱性残基发生改变的IGFBP - 5突变体与ECM的结合减少最为显著,尽管其他三个突变体R214A、R207A/K211N和K202A/R206N/R207A也有大幅减少。相比之下,其他三个突变体R201A/K202N/R206N/R208A、K217N/R218A和K211N与ECM的结合仅有极小程度的减少。这表明残基R207和R214对结合最为重要,而与之相邻的K211和R218的改变影响极小。为了确定ECM结合减少对细胞对IGF - I复制反应的影响,用编码ECM结合变化最大的IGFBP形式的突变体cDNA转染pSMC。与表达野生型蛋白的细胞相比,表达K211N、R214A、R217A/R218A和K202A/R206N/R207A突变体的培养物中IGFBP - 5的ECM含量分别降低了79.6%和71.7%。相比之下,R201A/K202N/R206N/R208A突变体的丰度仅降低了14%。表达两种ECM结合减少的突变体的细胞对IGF - I的DNA合成反应降低,但表达R201A/K202N/R206N/R208A突变体的细胞对IGF - I反应良好。这些发现表明,第207和214位的特定碱性氨基酸介导了IGFBP - 5与pSMC/ECM的结合。组成性表达与ECM弱结合的突变体的平滑肌细胞对IGF - I的反应较弱,这表明IGFBP - 5与ECM的结合是决定细胞反应性的一个重要变量。